← feed

Is NCT03229798 results overdue?

Yes — results are overdue. Primary completion was 2018-03-28; the FDAAA-801 reporting deadline (2019-03-28) passed 2688 days ago and no results are posted on ClinicalTrials.gov.

Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)

NCT IDNCT03229798 ↗
SponsorSorrento Therapeutics, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-03-28 (ACTUAL)
Reporting deadline2019-03-28 (completion + 365d)
Days overdue2688
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: yes
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 6ffddd5ae9363c99… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03229798. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →